Literature DB >> 24323398

Normoxic or hypoxic CD44/CD41 a₂ B₁ integrin-positive prostate PC3 cell side fractions and cancer stem cells.

K M Anderson1, P Guinan, M Rubenstein.   

Abstract

A CD44/a 2 B 1- (CD41 integrin) and B-catenin-labeled fraction of PC3 prostate cancer cells is able to reconstitute cells representative of the original tumor in immuno-deficient mice (Li et al. in Cancer Res 68:1820-1825, 2008). After 48 h of culture under nitrogen with a resulting medium pH of 7.8, sorted hypoxic PC3 cells yielded a higher percentage and concentration/10(5) of cells in a doubly labeled (DL) CD44(+)/CD41(+) side fraction compared with control cells cultured under normoxia (5 % CO2 in the ambient atmosphere at 37 °C). When the rise in pH was prevented (95 % N2, 5 % CO2), the difference in sorted hypoxic cell numbers remained. Sorted N and H DL cells and CD44(+)/CD41(-) cells were cultured under standard conditions. After 1-2 weeks, the number of attached colonies from formerly hypoxic cells, whether previously cultured with N2 or 95 % N2 + 5 % CO2, exceeded the number of doubly labeled normoxic cells, consistent with their greater initial concentration. Cultured sorted N or H CD44(+)/CD41(-) cells resulted in monolayers containing a small percentage of DL cells. Recovery of greater percentage and numbers of putative cancer stem cells, confirmed by quantitative cell sorting after culture under hypoxic conditions, is consistent with their greater relative numbers present in hypoxic niches. In addition, the report that neither CD44(+) nor CD41(+) epitopes were preferentially associated with FAM65B(high)/MF12(low)/LEF1(low) PC3 cells able to reconstitute tumors in immuno-deficient mice (Zhang and Waxman in Mol Cancer 9:319-330, 2010) suggests an in vitro mimic of tumor cell heterogeneity observed in epithelial cancers.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24323398     DOI: 10.1007/s12032-013-0779-1

Source DB:  PubMed          Journal:  Med Oncol        ISSN: 1357-0560            Impact factor:   3.064


  17 in total

1.  Prospective identification of tumorigenic prostate cancer stem cells.

Authors:  Anne T Collins; Paul A Berry; Catherine Hyde; Michael J Stower; Norman J Maitland
Journal:  Cancer Res       Date:  2005-12-01       Impact factor: 12.701

Review 2.  Cancer stem cells: distinct entities or dynamically regulated phenotypes?

Authors:  Yunqing Li; John Laterra
Journal:  Cancer Res       Date:  2012-02-01       Impact factor: 12.701

3.  The effect of normoxia and hypoxia on a prostate (PC-3) CD44/CD41 cell side fraction.

Authors:  K M Anderson; P Guinan; M Rubenstein
Journal:  Anticancer Res       Date:  2011-02       Impact factor: 2.480

4.  Identification of putative stem cell markers, CD133 and CXCR4, in hTERT-immortalized primary nonmalignant and malignant tumor-derived human prostate epithelial cell lines and in prostate cancer specimens.

Authors:  Jun Miki; Bungo Furusato; Hongzhen Li; Yongpeng Gu; Hiroyuki Takahashi; Shin Egawa; Isabell A Sesterhenn; David G McLeod; Shiv Srivastava; Johng S Rhim
Journal:  Cancer Res       Date:  2007-04-01       Impact factor: 12.701

5.  Cancer. Heterogeneity and tumor history.

Authors:  Darryl Shibata
Journal:  Science       Date:  2012-04-20       Impact factor: 47.728

6.  Cancer stem cells in solid tumors: elusive or illusive?

Authors:  Yvonne Welte; James Adjaye; Hans R Lehrach; Christian Ra Regenbrecht
Journal:  Cell Commun Signal       Date:  2010-05-11       Impact factor: 5.712

7.  In vitro effects of dichloroacetate and CO2 on hypoxic HeLa cells.

Authors:  K M Anderson; J Jajeh; P Guinan; M Rubenstein
Journal:  Anticancer Res       Date:  2009-11       Impact factor: 2.480

8.  Suppression of human breast tumors in NOD/SCID mice by CD44 shRNA gene therapy combined with doxorubicin treatment.

Authors:  Phuc Van Pham; Ngoc Bich Vu; Thuy Thanh Duong; Tam Thanh Nguyen; Nhung Hai Truong; Nhan Lu Chinh Phan; Tue Gia Vuong; Viet Quoc Pham; Hoang Minh Nguyen; Kha The Nguyen; Nhung Thi Nguyen; Khue Gia Nguyen; Lam Tan Khat; Dong Van Le; Kiet Dinh Truong; Ngoc Kim Phan
Journal:  Onco Targets Ther       Date:  2012-05-07       Impact factor: 4.147

9.  PC3 prostate tumor-initiating cells with molecular profile FAM65Bhigh/MFI2low/LEF1low increase tumor angiogenesis.

Authors:  Kexiong Zhang; David J Waxman
Journal:  Mol Cancer       Date:  2010-12-29       Impact factor: 27.401

10.  Distant metastasis occurs late during the genetic evolution of pancreatic cancer.

Authors:  Shinichi Yachida; Siân Jones; Ivana Bozic; Tibor Antal; Rebecca Leary; Baojin Fu; Mihoko Kamiyama; Ralph H Hruban; James R Eshleman; Martin A Nowak; Victor E Velculescu; Kenneth W Kinzler; Bert Vogelstein; Christine A Iacobuzio-Donahue
Journal:  Nature       Date:  2010-10-28       Impact factor: 49.962

View more
  1 in total

Review 1.  Prostate cancer and new insights in angiogenesis.

Authors:  Sanja Stifter; Gordana Dorđević
Journal:  Front Oncol       Date:  2014-09-10       Impact factor: 6.244

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.